by Benjamin H. Rudolph and Viqar Aslam, Aptagen, Inc. One company shows the world that stem cell research isn't coing away -- and receives a worldwide ctroversy in the process.
Viqar Aslam
Advertisement
Articles by Viqar Aslam
Advertisement
Latest Updated Articles
- Your Vested Interests: The War of the West
January 15th 2002
Advertisement
Advertisement
Trending on BioPharm International
1
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
2
argenx Agrees to Buy Unnatural Products in Up to $1.15 Billion Deal
3
Janux’s JANX011 T-Cell Engager Shows Deep B-Cell Depletion in Phase 1 Healthy Volunteer Study
4
UCB Reports 24-Week Bimekizumab (Bimzelx) vs Risankizumab Data in PsA
5